Palo Alto Investors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-94,850
| Closed | -$17.4M | – | 43 |
|
|
2021
Q2 | $17.4M | Sell |
94,850
-140,426
| -60% | -$25.8M | 0.96% | 19 |
|
|
2021
Q1 | $36M | Sell |
235,276
-268,153
| -53% | -$41M | 2.05% | 16 |
|
|
2020
Q4 | $78.7M | Buy |
503,429
+45,900
| +10% | +$7.17M | 4.12% | 9 |
|
|
2020
Q3 | $52.4M | Buy |
457,529
+12,900
| +3% | +$1.48M | 2.87% | 11 |
|
|
2020
Q2 | $49.9M | Sell |
444,629
-197,862
| -31% | -$22.2M | 3% | 12 |
|
|
2020
Q1 | $57.7M | Sell |
642,491
-235,609
| -27% | -$21.2M | 4.83% | 11 |
|
|
2019
Q4 | $95M | Sell |
878,100
-79,850
| -8% | -$8.64M | 5.23% | 9 |
|
|
2019
Q3 | $93.8M | Sell |
957,950
-65,830
| -6% | -$6.45M | 6.25% | 7 |
|
|
2019
Q2 | $134M | Sell |
1,023,780
-205,250
| -17% | -$26.9M | 6.52% | 5 |
|
|
2019
Q1 | $166M | Buy |
1,229,030
+24,702
| +2% | +$3.34M | 6.93% | 5 |
|
|
2018
Q4 | $117M | Buy |
1,204,328
+4,127
| +0.3% | +$402K | 6.24% | 5 |
|
|
2018
Q3 | $167M | Buy |
1,200,201
+13,774
| +1% | +$1.91M | 6.74% | 5 |
|
|
2018
Q2 | $147M | Buy |
1,186,427
+50,582
| +4% | +$6.28M | 5.89% | 6 |
|
|
2018
Q1 | $127M | Buy |
1,135,845
+18,203
| +2% | +$2.03M | 5.41% | 7 |
|
|
2017
Q4 | $134M | Buy |
1,117,642
+37,300
| +3% | +$4.46M | 5.76% | 6 |
|
|
2017
Q3 | $152M | Buy |
1,080,342
+49,400
| +5% | +$6.93M | 6.38% | 6 |
|
|
2017
Q2 | $125M | Buy |
1,030,942
+3,882
| +0.4% | +$472K | 5.86% | 5 |
|
|
2017
Q1 | $125M | Buy |
1,027,060
+313,318
| +44% | +$38M | 5.89% | 5 |
|
|
2016
Q4 | $87.3M | Buy |
713,742
+152,042
| +27% | +$18.6M | 4.98% | 6 |
|
|
2016
Q3 | $68.8M | Buy |
561,700
+222,300
| +65% | +$27.2M | 4% | 8 |
|
|
2016
Q2 | $39.6M | Buy |
+339,400
| New | +$39.6M | 2.99% | 11 |
|